India's Richest People 2026 edition · 1 director · Source: Hurun India
- #1,545 SS Vanangamudi ₹1,300 Cr
Revenue · FY 2025
₹1.31 Cr
▼ 45% YoY
Net profit · FY 2025
₹62.14 Lakh
Net margin 47.4%
EBITDA · FY 2025
₹78.42 Lakh
EBITDA margin 59.8%
Authorised capital
₹26 Cr
Registered with MCA
Paid-up capital
₹25.95 Cr
Issued & subscribed
Open charges
₹3.74 Cr
Satisfied ₹126.68 Cr
Company age
24 yrs
Est. 2002
Directors on board
4
As per MCA filings
About Vanan Pharma Private Limited
Data last updated:
Vanan Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Apex Laboratories Private Limited. It operates in the real estate financing segment of the financial services sector. It was incorporated on 20 November 2002 and has been in existence for over 24 years.
Its director SS Vanangamudi is #1,545 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2002PTC049892. Its GSTIN is 33AABCV6168N1ZV (Tamil Nadu).
The company has an authorised share capital of ₹26 Cr and a paid-up capital of ₹25.95 Cr. It is led by directors including Srinivasan Murali and Sulur Vanangamudi Subramaniam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3rd Floor SIDCO Garment Complex Guindy, Chennai, Tamil Nadu, India – 600032.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.31 Cr, a decline of 45% compared to the previous year. For the same year it recorded a net profit of ₹62.14 Lakh (net margin 47.4%) and EBITDA of ₹78.42 Lakh (EBITDA margin 59.8%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 20% over five years.
The company is associated with 1 brand: Vanan Pharma. As per MCA filings, the company has open charges of ₹3.74 Cr and satisfied charges of ₹126.68 Cr on record. Court records list 5 cases involving the company, including 5 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vananpharma.com.
Company details
CIN U24231TN2002PTC049892
Registration Number 049892
Incorporation Date 20 November 2002
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Apex Laboratories Private Limited
Compliance Status Active Compliant
Key People
Srinivasan Murali Director Sulur Vanangamudi Subramaniam Director Usha Vanangamudi Director Recognitions & Rankings of Vanan Pharma
Contact details
Vanan Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its website is vananpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address3rd Floor SIDCO Garment Complex Guindy, Chennai, Tamil Nadu, India – 600032
- IndustryFinancial Services, Real Estate Financing
To see the full contact details of Vanan Pharma Private Limited, buy the company report.
Comprehensive company report
Vanan Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Vanan Pharma operates one associated brand: Vanan Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops patented creams for skin infections, burns, and dermatitis treatments globally. | vananpharma.com |
Financials of Vanan Pharma Private Limited
FY 2025 filings availableVanan Pharma Private Limited reported revenue of ₹1.31 Cr (down 45% YoY) for FY 2025.
Revenue · FY 2025
₹1.31 Cr ▼ 45%
Net profit · FY 2025
₹62.14 Lakh margin 47.4%
EBITDA · FY 2025
₹78.42 Lakh margin 59.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 45%
3 years · compounded
▲ 34%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▼ 54%
3 years · compounded
▲ 16%
5 years · compounded
▲ 10%
Revenue fell 45% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 20%. EBITDA fell 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹78.42 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹62.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 59.8% | ||||
| Net Profit Margin | 47.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vanan Pharma Private Limited, buy the company report.
Board of directors of Vanan Pharma Private Limited
Vanan Pharma has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasan Murali | Director | 01 Sep 2022 | 4 Years 1 Months | Current |
| Sulur Vanangamudi Subramaniam | Director | 15 Sep 2010 | 16 Years 1 Months | Current |
| Usha Vanangamudi Also directs: Yali Eco Goods LLP | Director | 01 Apr 2023 | 3 Years 6 Months | Current |
| Vishagan Also directs: Halez Hospitality Services Private Limited, Apex Laboratories Private Limited, Apex Exports Private Limited and 1 more | Director | 01 Oct 2021 | 5 Years 0 Months | Current |
Auditor
Vanan Pharma Private Limited is audited by K.S.JAGANNATHAN & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.S.JAGANNATHAN & CO | FY 2023 | 001207S |
Shareholding
The shareholding of Vanan Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vanan Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.74 Cr
Satisfied charges
₹126.68 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Mar 2014 | 10495903 | Electronica Finance Limited | ₹22.67 Lakh | Open | |
| 25 Feb 2014 | 10481117 | Electronica Finance Limited | ₹71.7 Lakh | Open | |
| 29 Sep 2009 | 10179303 | Axis Bank Ltd | ₹2.8 Cr | Open | |
| 15 Jul 2013 | 10441086 | Dbs Bank Ltd | ₹11.5 Cr | Satisfied | |
| 30 Jul 2010 | 10237361 | Axis Bank Ltd | ₹33.67 Cr | Satisfied |
To see the full charge records of Vanan Pharma Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Vanan Pharma Private Limited has 5 court cases on record: 5 filed by Vanan Pharma. All cases are disposed.
Total cases
5
Filed by the company
5
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 0 | 0 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Court case (COMP.A) | Filed by the company | Disposed |
| Madras High Court | Company petition | Filed by the company | Disposed |
| High Court, TAMIL NADU | Writ petition | Filed by the company against The Sub Registrar, | Disposed |
| High Court, TAMIL NADU | Writ petition | Filed by the company against The Sub Registrar and 1 other | Disposed |
To see the full case history of Vanan Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vanan Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vanan Pharma Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
Active EPFO establishments
1
GST
Vanan Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AABCV6168N1ZV | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vanan Pharma Private Limited, buy the company report.
Recent activity
Vanan Pharma Private Limited has 8 board changes on record since 2010: 4 appointments and 4 cessations. The latest: Usha Vanangamudi was appointed as Director on 01 Apr 2023.
AGM
Vanan Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vanan Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Usha Vanangamudi was appointed as Director.
Ceased
Srinivasan Murali ceased to be Additional Director.
Ceased
Vishagan ceased to be Additional Director.
Appointed
Srinivasan Murali was appointed as Director.
Appointed
Vishagan was appointed as Director.
Charges
A charge registered on 30 Jul 2010 via Charge ID 10237361 with Axis Bank Ltd was fully satisfied on 22 Sep 2017.
Charges
A charge registered on 02 Nov 2007 via Charge ID 10090606 with State Bank Of India was fully satisfied on 06 Jan 2017.
Charges
A charge registered on 15 Jul 2013 via Charge ID 10441086 with Dbs Bank Ltd was fully satisfied on 26 Dec 2016.
Charges
A charge with Electronica Finance Limited amounted to Rs. 0.23 Cr with Charge ID 10495903 was registered on 29 Mar 2014.
Charges
A charge with State Bank Of India of Rs. 81.51 Cr registered on 02 Nov 2007 with Charge ID 10090606 was modified on 06 Mar 2014.
11 earlier events are in the company report.
Frequently asked questions
Vanan Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in real estate financing, within the financial services industry. It was incorporated on 20 November 2002 (24+ years old) and is registered under CIN U24231TN2002PTC049892.
Vanan Pharma has 4 current directors:
- Srinivasan Murali - Director
- Sulur Vanangamudi Subramaniam - Director
- Usha Vanangamudi - Director
- Vishagan - Director
The latest financial statements of Vanan Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vanan Pharma is 33AABCV6168N1ZV, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Vanan Pharma is U24231TN2002PTC049892. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vanan Pharma has 5 court cases on record: 5 filed by the company.
Vanan Pharma was incorporated on 20 November 2002, making it 24+ years old. It is registered with the Registrar of Companies, Chennai.
Usha Vanangamudi was appointed as Director on 01 Apr 2023. Srinivasan Murali ceased to be Additional Director on 30 Sep 2022. Vishagan ceased to be Additional Director on 30 Sep 2022. Vanan Pharma has 8 board changes on record in total.
Vanan Pharma can be reached through the website vananpharma.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Vanan Pharma is at 3rd Floor SIDCO Garment Complex Guindy, Chennai, Tamil Nadu, India – 600032.